Johnston, Chambless
Johnston, Chambless was paid $391K by Medicaid between Jan 2018 and Nov 2019, across 18 billing codes. Its largest line is H2010, Comprehensive medication services, per 15 minutes — 75% of everything it billed.
33Billing provider infoJOHNSTON, CHAMBLESS
JOHNSON CITY, TN 37601
JOHNSON CITY, TN 37601
33aNPI1790972628assigned 09/25/2007
33bProvider typeStudent in an Organized Health Care Education/Training Program
28Total paid$391K
24GClaims8,464
24DCodes billed18
24AFirst – last monthJan 2018 – Nov 2019
Compared with peers
Next to other Student in an Organized Health Care Education/Training Program providers in Tennessee
Rank by total paid#7 of 74
Median peer was paid$23K
This provider vs. median17×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,010 | $97K | |
| 2019 | 5,454 | $294K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| H2010 | Comprehensive medication services, per 15 minutes | 75% | 2,152 | 968 | $292K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 11% | 1,833 | 1,037 | $45K |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 5.1% | 1,083 | 608 | $20K |
| 99408 | 3.2% | 550 | 306 | $12K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.9% | 179 | 149 | $8K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 1.5% | 406 | 291 | $6K |
| 99407 | <1% | 305 | 231 | $2K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 269 | 187 | $2K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 949 | 541 | $1K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 12 | 12 | $749.51 |
| 99490 | Ccm add 20min | <1% | 28 | 20 | $668.90 |
| 99406 | <1% | 67 | 52 | $492.39 |
6 more codes
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 71 | $418.75 |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | <1% | 400 | $307.38 |
| 80348 | 0% | 42 | $0.00 | |
| 80362 | 0% | 40 | $0.00 | |
| 80346 | 0% | 23 | $0.00 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 55 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.